Last Week in Longevity #2
Your weekly business digest of everything that happened in Longevity.
Hi friends đ,
Here is your weekly digest of everything that happened in Longevity last week. We will cover:
Top longevity business news (international),
Closed funding rounds (international),
Events & meetups (Europe-only), and
Longevity jobs (Europe-only).
Letâs get started.
đ° Top longevity business news
Longevity.Technology has unveiled the âLongevity Clinics Worldâ directory to connect more than 350 validated longevity clinics globally with potential clients. Read more here.
Why this is interesting: With longevity clinics popping up on âevery cornerâ, finding the right one for you based on service portfolio, location, and price doesnât get easier. And how are consumers able to judge and compare the quality of all providers? Therefore, a platform that truly allows comparing providers and validates clinics (instead of being just a lead source for clinic providers), builds trust and is a good thing for consumers.Blood panel startup Superpower is cutting its price by 60%, so you can get 100+ blood biomarkers tested for USD 199. Read more here.
Why this is interesting: With so many new entrants to this market and a hard-to-differentiate diagnostic side of the business (can you credibly differentiate on quality? Most choose the path of simply adding MORE biomakers), this part of the business feels like it is getting commoditised. While it is great for customers when it comes to prices, companies will continue to focus on building value-added services like (personalised) supplements, AI health concierge etc., to differentiate. And it makes sense, because getting the data is just the beginning, and what you do with it is where the progress (or dare I say "magicâ?) happens.Danoneâs OIKOS has launched OIKOSâŻFUSION, a cultured dairy drink with a patented blend whey protein, leucine, and vitamin D, to help build and retain muscle mass during weight loss, especially for GLPâ1 users. Read more here.
Why this is interesting: Anyone who has ever tried to lose weight without losing lean muscle mass knows the struggle. While the need isnât new, and you can clearly manage it without another dairy drink (and I am not sure what they even patented), I think targeting GLP-1 users to support them on their journey is great from a marketing perspective.Seragon Biosciences introduced Enlivien, a new sleep and longevity supplement that combines antiâoxidative, antiâinflammatory, and mitochondrial support compounds to counteract damage from chronic sleep deprivation. The formulation is backed by Harvard research linking sleep loss to oxidative gut and neural damage, offering a molecularly targeted longevity solution. Read more here.
Why this is interesting: In our busy lives, prioritising sleep is not always possible (shout-out to all parents), so if there is a supplement to reduce the negative side-effects, supported by proper studies, sign me up.Life insurance firm Ethos and longevity company Lifeforce have teamed up and allow Ethosâ policyholders to access Lifeforceâs longevity platform. Read more here.
Why this is interesting: This collaboration signals a novel crossâindustry approach to longevity services by aligning insurance with healthyâliving engagement.
đ¸ Closed funding rounds
Eight Sleep - US$ 100M Series D
The New York-based (USA) company offers AI-powered sleep tech products (think: smart mattress and blanket) that promise to transform your bed into a preventive health device that can monitor, analyse, and enhance your sleep. Investors include: HSG, Valor Equity Partners, Founders Fund, Y Combinator, and others. Learn more here: Company, Article
Gameto - US$ 44M Series C
The Austin-based (USA) company develops stem cell-derived therapies for reproductive health. The Series C funding enables Gameto to complete the ongoing Phase 3 trial for its lead program, Fertilo, and file for regulatory approvals globally. Investors include: Overwater Ventures, with participation from Insight Partners, RA Capital, Two Sigma Ventures and others. Learn more here: Company, Article
Jocasta Neuroscience - US$ 35M Series A
The Scottsdale-based (USA) company is developing its proprietary klotho protein therapeutic, JN-0413, designed to replenish declining klotho levels, aimed at managing cognitive impairment linked to neurodegenerative diseases. Research in animals has shown that low levels accelerate aging and shorten lifespan, while elevated levels can extend life by up to 30 percent in certain experiments. Investors include Bain Capital, First Round, Khosla Ventures and Valor Equity Partners. Learn more here: Company, Article
August Health - US$ 29M Series B
The San Francisco-based (USA) company operates an Electronic Health Record (EHR) platform for senior living operators. Investors include Base10 Partners, General Catalyst, and Matrix Partners. Learn more here: Company, Article
Oneskin - US$ 20M Series A
The San Francisco-based (USA) company focuses on skin longevity, built around its proprietary peptide, OS-01, which supposedly reduces skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. The round was led by Prelude Growth Partners. Learn more here: Company, Article
Fountain Life - US$ 18M Series B
The Orlando-based (USA) company, which was co-founded by Tony Robbins, operates four longevity centres offering preventative diagnostics. The round was led by EOS Ventures, and existing shareholders. Learn more here: Company, Article
Isaac Health - US$ 10.5M Series A
The New York-based (USA) company offers a platform focused on screening, assessing, treating, and providing care management for brain health and dementia. Investors include Flare Capital Partners, Black Opal Ventures, and Industry Ventures. Learn more here: Company, Article
VentriJect - ⏠1.7M Series B
The Copenhagen-based (Denmark) company is a spinout from Aalborg University, which developed and sells a CE-marked medical device for VOâmax measurement for fitness and medical professionals. Investors include the Export and Investment Fund of Denmark (EIFO), HardTech Innovation Hub, and Investo Capital. Learn more here: Company, Article
đ Events & meetups
(DK) 12th Aging Research and Drug Discovery Meeting (Aug 25-29, 2025)
(LV) 3rd International Baltic Conference on Healthy Longevity (Sep 16-17, 2025)
(CH) St. Moritz Longevity Forum (Sep 18-21, 2025)
(CH) Longevity Investors Conference (Sep 22-25, 2025)
(UK) Healf Experience (Oct 3-5, 2025)
(CH) Global Longevity Summit (Oct 28-30, 2025)
(ES) 4th Longevity World Forum (Feb 18-20, 2026)
(CH) SIP Longevity Retreat (Apr 20-24, 2026)
(PT) 4th Global Longevity Med Summit (May 6-7, 2026)
(IE) Longevity Summit Dublin (Jun 24-26, 2026)
(NL) HLTH Europe (Jun 15-18, 2026)
(CZ) 8th World Aging & Rejuvenation Conference (Jun 18-19, 2026)
đź Longevity jobs
(Berlin) Co-Founder / CXO @ Life Summit
(Berlin) Head of Growth @ Juniper Germany
(Berlin) Product Development Manager Longevity @ Sunday Naturals
(Berlin) Founder Associate @ Kalia Lab
(MĂźnchen) Full Stack Developer @MoleQlar
(Karlsruhe) Medizinische Fachangestellte fĂźr Longevity-Medizin @ belleaesthetics
(Rostock) Postdoc: Bioinformatics and AI for Longevity @ Uni Rostock
(London) Registered Nurse @ London Longevity
(London) Product Manager @ Juniper UK
Keep building,
Fabian
P.S. Got feedback, fun ideas, or longevity-related news? I would love to hear from you - just reach out by replying to this email.